Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
Study NCT ID:
NCT01698905
Status:
COMPLETED
Last Update Posted:
2025-09-02
First Post:
2012-10-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myeloid Leukemia | View |